• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于CRISPR-Cas的益生菌工程

CRISPR-Cas-Based Engineering of Probiotics.

作者信息

Liu Ling, Helal Shimaa Elsayed, Peng Nan

机构信息

National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, China.

CABIO Biotech (Wuhan) Co. Ltd., Wuhan, China.

出版信息

Biodes Res. 2023 Sep 29;5:0017. doi: 10.34133/bdr.0017. eCollection 2023.

DOI:10.34133/bdr.0017
PMID:37849462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10541000/
Abstract

Probiotics are the treasure of the microbiology fields. They have been widely used in the food industry, clinical treatment, and other fields. The equivocal health-promoting effects and the unknown action mechanism were the largest obstacles for further probiotic's developed applications. In recent years, various genome editing techniques have been developed and applied to explore the mechanisms and functional modifications of probiotics. As important genome editing tools, CRISPR-Cas systems that have opened new improvements in genome editing dedicated to probiotics. The high efficiency, flexibility, and specificity are the advantages of using CRISPR-Cas systems. Here, we summarize the classification and distribution of CRISPR-Cas systems in probiotics, as well as the editing tools developed on the basis of them. Then, we discuss the genome editing of probiotics based on CRISPR-Cas systems and the applications of the engineered probiotics through CRISPR-Cas systems. Finally, we proposed a design route for CRISPR systems that related to the genetically engineered probiotics.

摘要

益生菌是微生物学领域的瑰宝。它们已广泛应用于食品工业、临床治疗等领域。益生菌促进健康的效果尚不明确以及作用机制未知,是其进一步开发应用的最大障碍。近年来,各种基因组编辑技术已被开发并应用于探索益生菌的作用机制和功能修饰。作为重要的基因组编辑工具,CRISPR-Cas系统为益生菌的基因组编辑带来了新的进展。高效、灵活和特异性是使用CRISPR-Cas系统的优势。在此,我们总结了CRISPR-Cas系统在益生菌中的分类和分布,以及基于它们开发的编辑工具。然后,我们讨论基于CRISPR-Cas系统的益生菌基因组编辑以及通过CRISPR-Cas系统对工程益生菌的应用。最后,我们提出了一条与基因工程益生菌相关的CRISPR系统设计路线。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d2/10541000/d37b6f619fcd/bdr.0017.fig.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d2/10541000/0f3e40654d6a/bdr.0017.fig.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d2/10541000/d37b6f619fcd/bdr.0017.fig.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d2/10541000/0f3e40654d6a/bdr.0017.fig.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d2/10541000/d37b6f619fcd/bdr.0017.fig.002.jpg

相似文献

1
CRISPR-Cas-Based Engineering of Probiotics.基于CRISPR-Cas的益生菌工程
Biodes Res. 2023 Sep 29;5:0017. doi: 10.34133/bdr.0017. eCollection 2023.
2
Exploiting heterologous and endogenous CRISPR-Cas systems for genome editing in the probiotic Clostridium butyricum.利用异源和内源CRISPR-Cas系统对益生菌丁酸梭菌进行基因组编辑。
Biotechnol Bioeng. 2021 Jul;118(7):2448-2459. doi: 10.1002/bit.27753. Epub 2021 Apr 14.
3
CRISPR-Cas Technologies and Applications in Food Bacteria.CRISPR-Cas 技术及其在食品细菌中的应用。
Annu Rev Food Sci Technol. 2017 Feb 28;8:413-437. doi: 10.1146/annurev-food-072816-024723.
4
Evolution of CRISPR/Cas Systems for Precise Genome Editing.CRISPR/Cas 系统的进化用于精确基因组编辑。
Int J Mol Sci. 2023 Sep 18;24(18):14233. doi: 10.3390/ijms241814233.
5
Portable CRISPR-Cas9 System for Flexible Genome Engineering in Lactobacillus acidophilus, Lactobacillus gasseri, and Lactobacillus paracasei.便携式 CRISPR-Cas9 系统在嗜酸乳杆菌、格氏乳杆菌和副干酪乳杆菌中的灵活基因组工程。
Appl Environ Microbiol. 2021 Feb 26;87(6). doi: 10.1128/AEM.02669-20.
6
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.基于 CRISPR 的基因组编辑技术的最新进展及其在心血管研究中的应用。
Mil Med Res. 2023 Mar 10;10(1):12. doi: 10.1186/s40779-023-00447-x.
7
Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.利用内源性 CRISPR-Cas 系统对酪丁酸梭菌进行多重基因组编辑,并对该菌株进行工程改造以提高丁醇产量。
Metab Eng. 2018 May;47:49-59. doi: 10.1016/j.ymben.2018.03.007. Epub 2018 Mar 9.
8
Combining omics technologies with CRISPR-based genome editing to study food microbes.将组学技术与基于 CRISPR 的基因组编辑相结合来研究食品微生物。
Curr Opin Biotechnol. 2020 Feb;61:198-208. doi: 10.1016/j.copbio.2019.12.027. Epub 2020 Feb 5.
9
CRISPR-based engineering of next-generation lactic acid bacteria.基于 CRISPR 的新一代乳酸菌工程改造。
Curr Opin Microbiol. 2017 Jun;37:79-87. doi: 10.1016/j.mib.2017.05.015. Epub 2017 Jun 13.
10
CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.用于基因组编辑的CRISPR-Cas:分类、机制、设计及应用
Int J Biol Macromol. 2023 May 31;238:124054. doi: 10.1016/j.ijbiomac.2023.124054. Epub 2023 Mar 17.

引用本文的文献

1
Engineering the Microbiome: a Novel Approach to Managing Autoimmune Diseases.工程化微生物群:一种治疗自身免疫性疾病的新方法。
Neuromolecular Med. 2025 Sep 5;27(1):63. doi: 10.1007/s12017-025-08879-5.
2
Intratumoral microbiota: implications for cancer progression and treatment.肿瘤内微生物群:对癌症进展和治疗的影响。
Front Microbiol. 2025 Jul 28;16:1551515. doi: 10.3389/fmicb.2025.1551515. eCollection 2025.
3
Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study.

本文引用的文献

1
Precise DNA cleavage using CRISPR-SpRYgests.利用 CRISPR-SpRYgests 进行精确的 DNA 切割。
Nat Biotechnol. 2023 Mar;41(3):409-416. doi: 10.1038/s41587-022-01492-y. Epub 2022 Oct 6.
2
Development and application of a rapid all-in-one plasmid CRISPR-Cas9 system for iterative genome editing in Bacillus subtilis.快速一体式质粒 CRISPR-Cas9 系统的开发与应用,用于枯草芽孢杆菌的迭代基因组编辑。
Microb Cell Fact. 2022 Aug 23;21(1):173. doi: 10.1186/s12934-022-01896-0.
3
Utilizing the Gastrointestinal Microbiota to Modulate Cattle Health through the Microbiome-Gut-Organ Axes.
利用合成生物学和代谢工具对肠道微生物群进行治疗性工程改造:以大肠杆菌Nissle 1917为模型案例研究的全面综述
Arch Microbiol. 2025 Aug 6;207(9):213. doi: 10.1007/s00203-025-04417-w.
4
From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis.从生态失调到精准治疗:解读膀胱癌发生过程中的肠-膀胱轴
Front Oncol. 2025 Jul 10;15:1630726. doi: 10.3389/fonc.2025.1630726. eCollection 2025.
5
Living hybrid material based on probiotic with photothermal properties inhibits PD-L1 expression after tumouricidal photothermal therapy.基于具有光热特性的益生菌的活性混合材料在肿瘤杀伤性光热治疗后可抑制PD-L1表达。
Biomater Transl. 2025 Mar 25;6(1):73-84. doi: 10.12336/biomatertransl.2025.01.006. eCollection 2025.
6
Deciphering probiotic potential: a comprehensive guide to probiogenomic analyses.解读益生菌潜力:益生菌基因组分析综合指南
Future Microbiol. 2025 May-Jun;20(7-9):611-622. doi: 10.1080/17460913.2025.2492472. Epub 2025 Apr 14.
7
Effects of Microorganisms in Fish Aquaculture from a Sustainable Approach: A Review.从可持续发展角度看微生物在鱼类养殖中的作用:综述
Microorganisms. 2025 Feb 21;13(3):485. doi: 10.3390/microorganisms13030485.
8
Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1.揭示铜绿假单胞菌PAO1中的内源性CRISPR-Cas系统。
PLoS One. 2024 Dec 31;19(12):e0312783. doi: 10.1371/journal.pone.0312783. eCollection 2024.
9
Paradigm of engineering recalcitrant non-model microorganism with dominant metabolic pathway as a biorefinery chassis.以优势代谢途径为生物炼制底盘的工程抗性非模式微生物范式。
Nat Commun. 2024 Nov 30;15(1):10441. doi: 10.1038/s41467-024-54897-5.
10
Insight into the natural regulatory mechanisms and clinical applications of the CRISPR-Cas system.对CRISPR-Cas系统的天然调控机制及临床应用的洞察。
Heliyon. 2024 Oct 18;10(20):e39538. doi: 10.1016/j.heliyon.2024.e39538. eCollection 2024 Oct 30.
利用胃肠道微生物群通过微生物组-肠道-器官轴调节牛的健康。
Microorganisms. 2022 Jul 10;10(7):1391. doi: 10.3390/microorganisms10071391.
4
Genomic and epigenetic landscapes drive CRISPR-based genome editing in .基因组和表观基因组景观驱动基于 CRISPR 的基因组编辑。
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2205068119. doi: 10.1073/pnas.2205068119. Epub 2022 Jul 20.
5
NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis.NF-κB 诱导激酶调节肠道免疫和稳态。
Front Immunol. 2022 Jun 27;13:895636. doi: 10.3389/fimmu.2022.895636. eCollection 2022.
6
Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice.工程丁酸产生菌对肥胖小鼠代谢紊乱和肠道菌群失调的正向干预作用。
Microbiol Spectr. 2022 Apr 27;10(2):e0114721. doi: 10.1128/spectrum.01147-21. Epub 2022 Mar 16.
7
Genetically stable CRISPR-based kill switches for engineered microbes.基于基因稳定的 CRISPR 工程菌杀伤开关
Nat Commun. 2022 Feb 3;13(1):672. doi: 10.1038/s41467-022-28163-5.
8
Anticancer activity of lactic acid bacteria.乳酸菌的抗癌活性。
Semin Cancer Biol. 2022 Nov;86(Pt 3):356-366. doi: 10.1016/j.semcancer.2021.12.013. Epub 2022 Jan 4.
9
CRISPR/Cas-Based Genome Editing for Human Gut Commensal Species.用于人类肠道共生菌的基于CRISPR/Cas的基因组编辑
ACS Synth Biol. 2022 Jan 21;11(1):464-472. doi: 10.1021/acssynbio.1c00543. Epub 2022 Jan 6.
10
Evolutionary plasticity and functional versatility of CRISPR systems.CRISPR 系统的进化可塑性和功能多样性。
PLoS Biol. 2022 Jan 5;20(1):e3001481. doi: 10.1371/journal.pbio.3001481. eCollection 2022 Jan.